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Abstract

Via 1H NMR it was determined that the amidation step from the acid
chloride produced two products. They were separated via column
chromatography and the minor product came off first in less polar solvents.
This minor product was the carboxylic acid derivative. The minor product
formed because of small amounts of water was getting into the reaction even
though the solvents/reagents had previously been dried over molecular sieves,
the glassware was dried in an oven prior to use, and the reaction was performed
under nitrogen.
The second product to come off in more polar solvents was the desired
amidation product. The product’s structure was confirmed by 1H NMR (Figure
5). In the 6.4-7.4 ppm range there is only one set of peaks indicating the other
byproducts were successfully removed.

Results and Discussions

Fungal infections are very common throughout the world, but there is a lack of
effective anti-fungal drugs. Potential anti-fungal drugs (e.g., D) are being
developed to inhibit Methionine Synthase; an enzyme responsible for making the
essential amino acid methionine. Previous investigations have shown that
compounds containing the Pterin group demonstrated potential anti-fungal activity;
however, it is challenging to synthesize these compounds because of low solubility
and low overall yield. To combat these issues, work is being conducted on adding
the Pterin group at the end of the synthesis thereby bypassing the low solubility
issue and improving the yield. So far, the Boc Amine group (B) has been added to
the starting material (A). Work is being done now in scaling up the (AB) reaction
and eventually adding the Pterin group (C).

Figure 2. New proposed synthetic route of a potential anti-fungal
compound. In this route the Boc Amine is added in the second step
and the Pterin group is added in the fourth step.

Background

The first step of this new proposed synthesis proved to be an easy and affective
reaction. Problems arose in the second step (DBU amidation) of the synthesis due
to formation of multiple products which lowered the yield and made isolation of
the desired product more difficult. Many different reaction conditions and solvents
were tried, but multiple products were formed (the multiple peaks present in top
spectrum in Figure 3).

Even though fungal infections are a common health risk, there is a lack of
effective drugs in the world to treat them. As the fungi mutates and becomes more
resistant against existing drugs, the desire for new and effective anti-fungal drugs is
high. Dr. Pruet’s research group is investigating new compounds that inhibit
Methionine Synthase (MetSyn), which is an enzyme that converts homocysteine in
methionine using a substituted folate molecule.
The structure of fungal MetSyn contains two adjacent active sites, but in the
human form the active sites are far apart. It is therefore possible to design a
synthetic compound that will bind to the fungi MetSyn and not the human MetSyn
(Figure 1).

When the amidation step was scaled up the carboxylic acid derivative
formed instead of the desired amidation product. This result indicated too much
water was getting into the reaction. To solve the water issue, the
solvents/reagents were dried more thoroughly (distillation, in some cases from
CaH2). This method of drying the reagents was affective and the amidation
product was formed in better yields.

Future Work
Figure 3. 1H NMR of failed DBU amidation. The bottom spectrum is
of starting material and the top spectrum is of the products.

The DBU amidation was proving to be nonviable so it was decided to try a
different synthetic route to get to the Boc Amine amidation product. The new route
proceeds through an acyl chloride intermediate product which is much more
reactive than the original ester. This should make the amidation step occur in
better yield.
Figure 1. The orange MetSyn is the fungi form, and the blue is the human
form.

Dr. Pruet and his research group examined several potential anti-fugal
compounds containing a Pterin group; however, it proved difficult to make in the
original synthetic route because of the Pterin group’s low solubility and the route’s
low yield. This posed a question of whether it would be easier to add the Pterin
group in the last step of the synthesis and therefore avoid the low solubility issue
and improve the yield.

Figure 5. 1H NMR spectra of the pure Boc Amine amidation product

• Scale up the amidation step
• Continue with the synthesis
• Find an alternative intermediate that is less susceptible to water
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